IRIS
SARMATI, LOREDANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 59.444
AS - Asia 10.132
EU - Europa 8.264
SA - Sud America 1.498
AF - Africa 212
OC - Oceania 104
Continente sconosciuto - Info sul continente non disponibili 26
Totale 79.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 59.091
SG - Singapore 4.464
IT - Italia 1.990
CN - Cina 1.795
BR - Brasile 1.224
RU - Federazione Russa 1.174
DE - Germania 1.066
HK - Hong Kong 961
VN - Vietnam 790
IE - Irlanda 713
UA - Ucraina 713
KR - Corea 673
FR - Francia 475
GB - Regno Unito 465
SE - Svezia 427
BD - Bangladesh 413
FI - Finlandia 395
JP - Giappone 279
IN - India 227
PL - Polonia 212
CA - Canada 196
NL - Olanda 157
ES - Italia 112
AU - Australia 95
AR - Argentina 93
MX - Messico 90
AT - Austria 89
ID - Indonesia 83
TR - Turchia 79
BE - Belgio 76
ZA - Sudafrica 72
IQ - Iraq 68
CZ - Repubblica Ceca 51
PK - Pakistan 45
CO - Colombia 44
EC - Ecuador 35
PH - Filippine 34
CL - Cile 33
VE - Venezuela 25
LT - Lituania 24
MA - Marocco 24
SA - Arabia Saudita 22
CH - Svizzera 20
KG - Kirghizistan 20
PY - Paraguay 20
TN - Tunisia 20
AE - Emirati Arabi Uniti 18
JO - Giordania 18
KE - Kenya 18
RO - Romania 18
UZ - Uzbekistan 18
IL - Israele 17
EG - Egitto 16
TW - Taiwan 16
EU - Europa 14
JM - Giamaica 14
IR - Iran 13
KZ - Kazakistan 13
DZ - Algeria 12
GR - Grecia 12
HN - Honduras 11
PE - Perù 11
CM - Camerun 10
NZ - Nuova Zelanda 9
PT - Portogallo 9
AL - Albania 8
BH - Bahrain 8
DO - Repubblica Dominicana 8
NP - Nepal 8
UY - Uruguay 8
ET - Etiopia 7
LB - Libano 7
MY - Malesia 7
TH - Thailandia 7
AZ - Azerbaigian 6
BG - Bulgaria 6
CR - Costa Rica 6
LV - Lettonia 6
NG - Nigeria 6
NO - Norvegia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BA - Bosnia-Erzegovina 5
HR - Croazia 5
NI - Nicaragua 5
SC - Seychelles 5
SK - Slovacchia (Repubblica Slovacca) 5
XK - ???statistics.table.value.countryCode.XK??? 5
BB - Barbados 4
MD - Moldavia 4
OM - Oman 4
PA - Panama 4
RS - Serbia 4
SI - Slovenia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
DK - Danimarca 3
GA - Gabon 3
KH - Cambogia 3
Totale 79.629
Salva come PNG Salva come JPEG
Città #
Woodbridge 14.891
Wilmington 14.682
Houston 11.306
Singapore 2.487
Fairfield 1.824
Ashburn 1.516
Ann Arbor 1.390
Chandler 1.361
San Jose 1.307
Hong Kong 938
Seattle 776
Beijing 703
Rome 673
Cambridge 630
Dublin 623
Jacksonville 593
New York 564
Medford 448
Council Bluffs 438
Los Angeles 437
The Dalles 411
Dearborn 396
Santa Clara 365
Ho Chi Minh City 256
Tokyo 256
Lawrence 214
Helsinki 206
Hanoi 197
Buffalo 191
Milan 172
Dallas 169
Moscow 166
Munich 147
Orem 146
Lauterbourg 140
San Diego 140
São Paulo 133
Kraków 121
London 101
Nuremberg 100
Menlo Park 96
Zhengzhou 85
North Bergen 83
Chicago 82
Boardman 77
Brussels 75
Chennai 74
Mülheim 72
Redondo Beach 70
Montreal 69
Frankfurt am Main 65
Phoenix 64
Warsaw 63
Toronto 56
Stockholm 54
Denver 52
Jakarta 51
Brooklyn 50
Amsterdam 48
Johannesburg 48
Manchester 47
Rio de Janeiro 45
Palo Alto 44
Guangzhou 43
Atlanta 40
Sydney 40
San Mateo 39
Shanghai 39
Lappeenranta 38
Hangzhou 37
Naples 37
San Francisco 37
Falls Church 36
Norwalk 34
Redwood City 33
Melbourne 32
Mexico City 32
Brno 31
Da Nang 31
Engelhard 31
Hefei 31
Colorado Springs 30
Salt Lake City 30
Verona 30
Washington 30
Vienna 29
Mumbai 28
Ankara 27
Belo Horizonte 27
Boston 27
Columbus 27
Haiphong 27
Nanjing 27
Poplar 27
Baghdad 26
Seoul 26
Creede 25
Mountain View 25
Paris 25
Florence 23
Totale 64.241
Salva come PNG Salva come JPEG
Nome #
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 577
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 577
A randomized controlled study for the evaluation of the activity of a triple combination of zidovudine, thymosin-alpha(1) and interferon-alpha in HIV-infected individuals with CD4 counts between 200 and 500 cells/mm(3) 540
Microbiologic characteristics and predictors of mortality in bloodstream infections in intensive care unit patients: A 1-year, large, prospective surveillance study in 5 Italian hospitals 538
Emergence of KPC-producing Klebsiella pneumoniae in Italy 537
Leflunomide-induced DRESS syndrome 529
18-Fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis. 522
Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals 517
Human herpesvirus-8 infection in pregnancy and labor: Lack of evidence of vertical transmission 504
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 496
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 486
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy 484
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects. 482
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 481
Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment 480
Infection with human herpesvirus type 8 and Kaposi's sarcoma in a central Italian area formerly endemic for malaria 480
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens 477
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 476
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 476
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs 474
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (< 400 HIV-RNA cp/ml) during different antiretroviral regimens 467
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing 464
Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma 464
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 463
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 462
Candida Albicans Peritoneal Infection in a patient with slerosing Encapsulating Peritonitis under continous peritoneal dialysis. Efficacy of intra-abdominal Amphotericin B and negative pressure after failure of a systemic therapy 462
Advances in herpesvirus diagnosis 459
Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy. 452
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 452
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART 451
Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy 449
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment 447
Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects 445
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy 445
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations 444
A case of rhabdomiolysis associated with raltegravir use 444
High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. 444
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis 443
Cortical sources of resting state electroencephalographic rhythms probe brain function in naïve HIV individuals 441
HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity 439
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration 437
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. 437
ellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy. 437
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 437
Human herpesvirus 8 and human herpesvirus 2 infections in prison population 436
Viral growth assay to evaluate the replicative capacity of HIV-1 isolates 434
Correlates of HIV, HBV, and HCV infections in a prison inmate population: Results from a multicentre study in Italy 431
Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (invirase) treatment 430
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: impact on susceptibility to first-line strategies including Integrase strand-transfer inhibitors 430
Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy 429
Five human immunodeficiency virus type 1 phenotypic variants with different MT-2 cell tropisms correlate with prognostic markers of disease 429
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 429
Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapy 428
Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient. 428
Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia 427
Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon 427
Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV 426
Complication of nasal piercing by Staphylococcus aureus endocarditis: a case report and a review of literature. 426
Plasma Viremia Titration and RNA Quantitation in ICD-p24 Negative HIV Type-1-Infected Patients 426
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 422
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study 421
Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon 420
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation 418
HBV, HCV, HDV AND HEV COINFECTIONS IN A COHORT OF HIV POSITIVE PATIENTS IN CAMEROON 417
Primary human herpesvirus 8 infection in immunocompetent children. 417
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy. 417
Prevalence trend and correlates of HHV-8 infection in HIV-infected patients 416
KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection 415
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 415
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 415
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 414
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 414
HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy 414
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity. 414
Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba 412
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians 407
Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy 405
High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment 404
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 404
Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS [1] 403
Erysipeloid cutaneous metastasis from bladder carcinoma 402
HHV-8 infection in African children 402
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy 400
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy. 400
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia 400
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 400
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review 399
Reply to 'Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides', by Barreiro et al. [2] 399
Serological testing for human herpesvirus 8 397
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 397
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 397
Stavudine protective function and emergence of lamivudine resistance [4] (multiple letters) 397
Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea 395
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation 394
Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. 394
Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. 394
null 393
ISS-NIA Study Group. Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection. 393
Human immunodeficiency virus polymorphisms and zidovudine resistance [3] (multiple letters) 392
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 389
Totale 43.972
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.031
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 0 0 0 0 0 0 150
2021/20222.889 117 226 146 170 124 396 205 145 302 233 172 653
2022/20233.599 324 298 224 517 297 756 271 242 341 31 191 107
2023/20241.713 213 44 167 102 163 343 81 124 39 122 44 271
2024/20257.789 286 1.344 731 642 272 544 767 464 771 762 620 586
2025/202614.014 1.148 595 1.334 1.215 1.217 591 1.826 1.585 1.755 1.214 834 700
Totale 80.884